UK launches ‘biomedical catalyst’ fund
April 11, 2012Biotechnology, SMEs, biomedical catalyst, strategy for life sciences
A £180 million government fund to help innovative small and medium sized enterprises (SMEs) and academics to develop solutions to …
Amgen to acquire kidney disease specialist for $315m
April 11, 2012Sales and Marketing Amgen, KAI Pharmaceuticals
Amgen will acquire KAI Pharmaceuticals for $315 million to bolster its late-stage pipeline. The deal, which should be completed within …
A more ‘nimble approach’ needed for CRO-pharma partnerships
April 10, 2012Research and Development CRO, partnerships
Pharma firms need to create closer and more flexible relationships with their contract research organisations for better outcomes. This is …
J&J unveils plans to boost Doxil supplies
April 10, 2012Manufacturing and Production Ben Venue, Doxil, J&J, JJ, drug shortages
Johnson & Johnson is planning to transfer filling and packaging of Doxil to another supplier in an attempt to alleviate …
Investors ramp up pressure on AZ chief
April 10, 2012Sales and Marketing AstraZeneca, David Brennan
AstraZeneca’s chief executive David Brennan is coming under increasing pressure from investors, and his future at the firm could be …
Codexis and Merck develop green Victrelis production
April 10, 2012Manufacturing and Production Codexis, Merck, manufacturing
Merck has teamed up with catalyst specialist Codexis to develop a more efficient manufacturing process for recently-approved hepatitis C treatment …
Alzheimer’s diagnostic comes with caveats
April 10, 2012Sales and Marketing Alzheimer's, Amyvid, lilly
A first-in-class test for Alzheimer’s disease has been approved by the FDA, but its makers have stressed its limitations.Lilly’s Amyvid …
Victoza superiority to Januvia made official by FDA
April 10, 2012Medical Communications, Sales and Marketing Januvia, Merck, Novo Nordisk, Victoza, diabetes
Novo Nordisk is now able to claim superiority for its diabetes drug Victoza compared to Merck’s rival treatment Januvia.The US …
Sheri McCoy resigns from Johnson & Johnson
April 10, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Johnson & Johnson, Sheri McCoy, resignation
Johnson & Johnson has announced that Sheri McCoy, vice chairman of the executive committee, will leave the company on April …
Submission of labels and leaflets in the UK
April 5, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Labelling, Wainwright Associates
The MHRA has announced procedural changes concerning the requirement to submit full-colour mock-ups of labels and patient leaflets for medicinal …
Pfizer heart drug gains new licence in UK
April 5, 2012Sales and Marketing Inspra, NHS, Pfizer, heart failure
Pfizer’s heart pill Inspra has gained a new licence in the UK to reduce the risk of death in patients …
Roche sponsors Twitter-based diabetes community
April 5, 2012Medical Communications Ignite Health, Roche, Twitter, diabetes
Roche is to sponsor a Twitter-based site devoted talk about diabetes, furthering its close links with online commentators. ‘Diabetes Nest’ …
The brain drain
April 5, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, R&D, brain drain, research and development
Concerns about the growing number of companies disinvesting from neuroscience research have been growing in recent years, and the latest …
Eric Abadie resigns as chair of the CHMP
April 5, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CHMP, Eric Abadie
Dr Eric Abadie has told the European Medicines Agency that he is resigning as chair of the Committee for Medicinal …
FDA grants priority review for Sanofi cancer drug
April 5, 2012Research and Development, Sales and Marketing Erbitux, FDA, Regeneron, Sanofi, Zaltrap, colorectal cancer, prostate cancer
The FDA has granted Sanofi and partner Regeneron priority review for their colorectal cancer drug Zaltrap. Zaltrap (aflibercept) is seeking a …
Drugmakers ‘premature’ in requests for metal impurity data
April 5, 2012Manufacturing and Production ICH, manufacturing, metal impurity
Pharmaceutical manufacturers are acting ‘prematurely’ when asking excipient suppliers to provide metal impurity levels, according to a new position paper …
Lonza names Ridinger as new chief executive
April 5, 2012Manufacturing and Production Cognis, Lonza, Ridinger
Swiss contract manufacturer and ingredients supplier Lonza has appointed Richard Ridinger as its new chief executive, replacing Stefan Borgas who …
AstraZeneca signs respiratory pact with Amgen
April 5, 2012Research and Development Amgen, AstraZeneca, MedImmune, respiratory
AstraZeneca has bought its way into Amgen’s inflammation portfolio with a $50 million upfront payment to co-develop and commercialise five …
Orphan Medicinal Products in the EU- Free Webinar
April 4, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Orphan Medicinal Products in the EU: Eligibility, Orphan Designation and IncentivesThe structure of this webinar is:Introduction: Legislative Basis and Criteria …
NHS spending on drugs fell in 2011
April 4, 2012Sales and Marketing NHS, cost savings, generic, patent, prescriptions, spend
The NHS in England spent less on its drugs budget last year, bucking the longstanding upward trend. This is because …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
